tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Plus Therapeutics Appeals Nasdaq Delisting Decision

Story Highlights
  • Plus Therapeutics regained compliance with Rule 5250(c)(1) after filing its Quarterly Report.
  • The company faces delisting due to non-compliance with equity requirements and plans to appeal.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Plus Therapeutics Appeals Nasdaq Delisting Decision

Elevate Your Investing Strategy:

Plus Therapeutics ( (PSTV) ) just unveiled an update.

On June 3, 2025, Plus Therapeutics, Inc. received a letter from Nasdaq stating that the company had regained compliance with Rule 5250(c)(1) after filing its Quarterly Report for the period ended March 31, 2025. However, the company was notified of non-compliance with the Minimum Stockholders’ Equity Requirement, leading to a decision to delist its securities unless an appeal is made. Plus Therapeutics plans to request a hearing to appeal this decision, during which its stock will continue trading on the Nasdaq Capital Market.

The most recent analyst rating on (PSTV) stock is a Buy with a $4.00 price target. To see the full list of analyst forecasts on Plus Therapeutics stock, see the PSTV Stock Forecast page.

Spark’s Take on PSTV Stock

According to Spark, TipRanks’ AI Analyst, PSTV is a Underperform.

The overall stock score is heavily impacted by the company’s challenging financial position and poor valuation metrics. Technical indicators also point to weak momentum. While there are some positive developments from the earnings call and strategic initiatives, these are overshadowed by financial and compliance risks.

To see Spark’s full report on PSTV stock, click here.

More about Plus Therapeutics

Average Trading Volume: 14,959,714

Technical Sentiment Signal: Sell

Current Market Cap: $11.54M

See more data about PSTV stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1